Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Ranked #93 for mothers · Grade C

OrderlyMeds review

⛔ FDA warning letter #728291 (Jun. 2026), which names orderlymeds.com. One of the few sites in this round to publish real cash prices for both compounded ($149/mo semaglutide, $299/mo tirzepatide) and FDA-approved brand-name options (Wegovy® $1,839/mo, Zepbound® $1,498/mo) — a named Chief Medical Officer, licensed in all 50 states, though no content addresses postpartum or PCOS.

$149/mo
Consult Medication
See plans at OrderlyMeds
  • HSA / FSA-eligible
  • Editor-vetted
  • No insurance needed
Compare top-rated alternatives for mothers ↓
Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.

OrderlyMeds at a glance

Semaglutide
$149/mo standard
Tirzepatide
$299/mo standard
Coverage
All 50 states
Brand-name
Yes

How we scored OrderlyMeds

Every factor comes from OrderlyMeds's own published pricing, disclosures and oversight, and the six combine into the 50/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.

Postpartum & breastfeeding guidance30/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit38/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Clinical oversight & labs62/100 · Weak

Oversight and lab support fall short of the top of this roster — the review below says exactly where.

True monthly cost68/100 · Weak

Cost is unpredictable or sits at the premium end.

Ongoing support58/100 · Weak

Support is thin once the prescription ships.

Cancellation fairness50/100 · Weak

Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.

How we verified this review

Last verified
August 2026
Confidence
medium

⛔ Added 26 August 2026: OrderlyMeds LLC dba OrderlyMeds holds FDA warning letter #728291, dated 8 June 2026. We confirmed it by reading the letter itself, which names orderlymeds.com. This review had been published for months without mentioning it. A letter discloses; it does not disqualify, and nothing about the ranking changed. $149 for semaglutide and $299 for tirzepatide — the standing 'thereafter' rates rather than the lowest-dose intro figure, which is the number that actually describes your second month onward. Brand-name Wegovy and Zepbound are sold for cash alongside them, in all fifty states.

What to expect when you sign up

We walked OrderlyMeds's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.

  1. 1Homepage and pricing page list both the intro starter price and the standing 'thereafter' price for both compounded molecules directly, before intake
  2. 2Also lists real cash prices for brand-name Wegovy® ($1,839/mo) and Zepbound® ($1,498/mo) on the same pricing page — one of the few sites in this round to publish brand-name cash prices at all
  3. 3A named Chief Medical Officer, Dr. Brian Spears, is credited with combining emergency-medicine and clinical-research experience
  4. 4A FAQ answer states 'Our providers are licensed to prescribe medication in all 50 states'

What we noticed

  • Publishing real brand-name (Wegovy/Zepbound) cash prices alongside compounded prices is unusually transparent — most competitors in this round either don't offer brand names or don't price them
  • The intro price ($74 or $149 for the first month) is explicitly a lowest-dose-only, pay-upfront-in-full starter rate — the standing 'thereafter' price is the honest ongoing cost, which is what's recorded here
  • Claims 125k customers and 1M+ total pounds lost as trust signals
  • No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS

Pricing

Prices re-verified

MedicationMonthlyPlan
Compounded semaglutide$149Standard monthly planListed as '$149/mo thereafter'; a lowest-dose starter tier is offered at $74/mo for the first month only, paid upfront in full.
Compounded tirzepatide$299Standard monthly planListed as '$299/mo thereafter'; a lowest-dose starter tier is offered at $149/mo for the first month only, paid upfront in full.
Brand semaglutide$1839Wegovy®Listed directly on the pricing page; drug billed at this price rather than through insurance.
Brand tirzepatide$1498Zepbound®Listed directly on the pricing page; drug billed at this price rather than through insurance.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what OrderlyMeds's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

What we like

  • Publishes real brand-name (Wegovy®, Zepbound®) cash prices alongside compounded prices — unusually transparent for this round
  • Named Chief Medical Officer (Dr. Brian Spears) with a stated clinical background
  • Explicitly licensed to prescribe in all 50 states, per a FAQ answer
  • Standing 'thereafter' price is disclosed alongside the lowest-dose intro rate, rather than only advertising the intro number

The caveats

  • ⛔ FDA warning letter #728291, dated June 8, 2026, to OrderlyMeds LLC dba OrderlyMeds, for false or misleading claims and misbranding — the letter names its own site
  • No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS
  • The lowest advertised price ($74 or $149) is a first-month-only, lowest-dose-only starter rate paid upfront in full — the standing price is meaningfully higher
  • No named compounding pharmacy found on the pages checked
  • No oral form offered

OrderlyMeds for mothers: our verdict

⛔ FDA warning letter #728291 (Jun. 2026), which names orderlymeds.com. One of the few sites in this round to publish real cash prices for both compounded ($149/mo semaglutide, $299/mo tirzepatide) and FDA-approved brand-name options (Wegovy® $1,839/mo, Zepbound® $1,498/mo) — a named Chief Medical Officer, licensed in all 50 states, though no content addresses postpartum or PCOS. It runs about $149/month — toward the affordable end of what we track.

We weigh OrderlyMeds the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.

What OrderlyMeds costs, in full

  • Compounded semaglutide — Standard monthly plan: $149/mo
  • Compounded tirzepatide — Standard monthly plan: $299/mo
  • Brand-name semaglutide — Wegovy®: $1839/mo
  • Brand-name tirzepatide — Zepbound®: $1498/mo

That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.

OrderlyMeds says the price covers the provider visit and the medication. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.

The medications OrderlyMeds prescribes

OrderlyMeds prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. Brand pens are available here alongside the compounded versions, and the on-label products come with the manufacturer's own pregnancy and lactation labeling — easier to hand to an OB.

Where OrderlyMeds fits — and where it doesn't — for mothers

A good fit if…

  • the monthly cost is a real barrier and you want a low, predictable number.
  • switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
  • uninterrupted nationwide access matters — a move for family shouldn't interrupt care.

Look elsewhere if…

  • a clean regulatory record is a dealbreaker — note the FDA warning flagged in the cons above.
  • you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.

Oversight, safety, and what we could verify

Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. It carries an FDA warning letter, flagged in the cons — read it before starting. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.

A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.

The bottom line

OrderlyMeds is a provider we list only with full disclosure — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.

The bottom line for mothers

Best for: Mothers who want to directly compare real compounded and brand-name cash prices on one page, or who may eventually want a brand-name pen without switching providers.

Alternatives to OrderlyMeds

Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.

  • CoreAge RxOur #1 pick

    One flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.

    Visit CoreAge Rx
  • A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.

    Visit Gala Health
  • One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.

    Visit Enhance MD

Keep comparing OrderlyMeds

OrderlyMeds, answered

How much does OrderlyMeds cost?
At last review, OrderlyMeds's lowest ongoing compounded rate was about $149 a month — $149/mo standard for semaglutide, $299/mo standard for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
Is OrderlyMeds safe to use while breastfeeding?
Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. OrderlyMeds is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
Does OrderlyMeds offer both semaglutide and tirzepatide?
Yes — OrderlyMeds offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
Where does OrderlyMeds rank for mothers?
OrderlyMeds scores 50/100 on our Metabolic-Fit Score and sits at #93. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.

Pricing, states and verification reflect OrderlyMeds's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers